IFP Advisors Inc increased its stake in Cigna Group (NYSE:CI – Free Report) by 32.8% during the fourth quarter, HoldingsChannel reports. The firm owned 13,599 shares of the health services provider’s stock after acquiring an additional 3,359 shares during the period. IFP Advisors Inc’s holdings in Cigna Group were worth $3,743,000 at the end of the most recent quarter.
A number of other institutional investors have also recently bought and sold shares of the stock. OLD National Bancorp IN increased its stake in Cigna Group by 3.7% in the 4th quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider’s stock worth $284,000 after purchasing an additional 37 shares in the last quarter. Physician Wealth Advisors Inc. increased its stake in Cigna Group by 1.5% in the 3rd quarter. Physician Wealth Advisors Inc. now owns 2,712 shares of the health services provider’s stock worth $782,000 after purchasing an additional 41 shares in the last quarter. Cookson Peirce & Co. Inc. increased its stake in Cigna Group by 0.8% in the 3rd quarter. Cookson Peirce & Co. Inc. now owns 4,953 shares of the health services provider’s stock worth $1,428,000 after purchasing an additional 41 shares in the last quarter. Signet Financial Management LLC increased its stake in Cigna Group by 0.6% in the 3rd quarter. Signet Financial Management LLC now owns 7,459 shares of the health services provider’s stock worth $2,150,000 after purchasing an additional 41 shares in the last quarter. Finally, Palumbo Wealth Management LLC increased its stake in Cigna Group by 2.3% in the 3rd quarter. Palumbo Wealth Management LLC now owns 1,927 shares of the health services provider’s stock worth $524,000 after purchasing an additional 43 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities analysts recently weighed in on the company. Truist Financial lifted their price target on Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a research note on Tuesday, February 17th. Royal Bank Of Canada lifted their price target on Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a research note on Friday, May 1st. Robert W. Baird set a $337.00 price target on Cigna Group in a research note on Friday, May 1st. Wells Fargo & Company lifted their price target on Cigna Group from $300.00 to $305.00 and gave the stock an “equal weight” rating in a research note on Friday, May 1st. Finally, UBS Group reissued a “buy” rating and issued a $375.00 price target on shares of Cigna Group in a research note on Monday, February 9th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Cigna Group has a consensus rating of “Moderate Buy” and a consensus target price of $338.55.
Insider Buying and Selling at Cigna Group
In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the transaction, the insider owned 32,647 shares in the company, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the sale, the insider directly owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 205,904 shares of company stock worth $60,277,068. 0.60% of the stock is currently owned by company insiders.
Cigna Group Stock Down 0.4%
Cigna Group stock opened at $281.84 on Friday. The firm has a market cap of $74.56 billion, a PE ratio of 11.95, a P/E/G ratio of 0.99 and a beta of 0.30. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. The firm’s 50 day moving average price is $276.12 and its two-hundred day moving average price is $276.03. Cigna Group has a twelve month low of $239.51 and a twelve month high of $338.89.
Cigna Group (NYSE:CI – Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.19. The firm had revenue of $68.52 billion for the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, research analysts predict that Cigna Group will post 30.39 EPS for the current fiscal year.
Cigna Group Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be paid a $1.56 dividend. This represents a $6.24 annualized dividend and a yield of 2.2%. The ex-dividend date is Thursday, June 4th. Cigna Group’s dividend payout ratio is currently 26.45%.
Cigna Group Company Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Further Reading
- Five stocks we like better than Cigna Group
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
- As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure
- Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA
- The Silver Lining of Last Week’s Hims & Hers Earnings Miss
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
